Skip to main content
EJNMMI Research
EJNMMI Research Cover Image
Fig. 7 | EJNMMI Research

Fig. 7

From: Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake

Fig. 7

Inhibition of [125I]MIBG uptake in isolated human platelets by different dilutions of murine plasma obtained from SSRI-treated mice. One hour before collecting plasma, mice intraperitoneally received the monoamine transporter inhibitor at the dose indicated in parenthesis. Data are from a representative experiment performed in duplicate and were confirmed by at least 2 experiments performed at slightly different conditions

Back to article page